Incidence of and Risk Factors for Incisional Hernia After Hepatectomy for Colorectal Liver Metastases.


Journal

Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: Netherlands
ID NLM: 9706084

Informations de publication

Date de publication:
11 2023
Historique:
received: 06 02 2023
accepted: 01 07 2023
medline: 22 11 2023
pubmed: 4 8 2023
entrez: 3 8 2023
Statut: ppublish

Résumé

Incisional hernia (IH) is common after major abdominal surgery; however, the incidence after hepatectomy for cancer has not been described. We analyzed incidence of and risk factors for IH after hepatectomy for colorectal liver metastases (CLM). Patients who underwent open hepatectomy with midline or reverse-L incision for CLM at a single institution between 2010 and 2018 were retrospectively analyzed. Postoperative CT scans were reviewed to identify IH and the time from hepatectomy to hernia. Cumulative IH incidence was calculated using competing risk analysis. Risk factors were assessed using Cox proportional hazards model analysis. The relationship between IH incidence and preoperative body mass index (BMI) was estimated using a generalized additive model. Among 470 patients (median follow-up: 16.9 months), IH rates at 12, 24, and 60 months were 41.5%, 51.0%, and 59.2%, respectively. Factors independently associated with IH were surgical site infection (HR: 1.54, 95% CI 1.16-2.06, P = 0.003) and BMI > 25 kg/m IH is common after open hepatectomy for CLM, particularly in obese patients and patients with surgical site infection. Surgeons should consider risk-mitigation strategies, including alternative fascial closure techniques.

Sections du résumé

BACKGROUND
Incisional hernia (IH) is common after major abdominal surgery; however, the incidence after hepatectomy for cancer has not been described. We analyzed incidence of and risk factors for IH after hepatectomy for colorectal liver metastases (CLM).
METHODS
Patients who underwent open hepatectomy with midline or reverse-L incision for CLM at a single institution between 2010 and 2018 were retrospectively analyzed. Postoperative CT scans were reviewed to identify IH and the time from hepatectomy to hernia. Cumulative IH incidence was calculated using competing risk analysis. Risk factors were assessed using Cox proportional hazards model analysis. The relationship between IH incidence and preoperative body mass index (BMI) was estimated using a generalized additive model.
RESULTS
Among 470 patients (median follow-up: 16.9 months), IH rates at 12, 24, and 60 months were 41.5%, 51.0%, and 59.2%, respectively. Factors independently associated with IH were surgical site infection (HR: 1.54, 95% CI 1.16-2.06, P = 0.003) and BMI > 25 kg/m
CONCLUSION
IH is common after open hepatectomy for CLM, particularly in obese patients and patients with surgical site infection. Surgeons should consider risk-mitigation strategies, including alternative fascial closure techniques.

Identifiants

pubmed: 37537494
doi: 10.1007/s11605-023-05777-8
pii: S1091-255X(24)00046-5
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2388-2395

Subventions

Organisme : NCI NIH HHS
ID : CA016672
Pays : United States
Organisme : NCI NIH HHS
ID : CA016672
Pays : United States

Informations de copyright

© 2023. The Society for Surgery of the Alimentary Tract.

Références

van Ramshorst GH, Eker HH, Hop WC, Jeekel J, Lange JF. Impact of incisional hernia on health-related quality of life and body image: a prospective cohort study. Am J Surg. 2012;204(2):144-50.  https://doi.org/10.1016/j.amjsurg.2012.01.012 .
doi: 10.1016/j.amjsurg.2012.01.012 pubmed: 22579232
Alli VV, Zhang J, Telem DA. Impact of incisional hernia development following abdominal operations on total healthcare cost. Surg Endosc. 2018;32(5):2381-6.  https://doi.org/10.1007/s00464-017-5936-8 .
doi: 10.1007/s00464-017-5936-8 pubmed: 29234938
Baucom RB, Ousley J, Beveridge GB, Phillips SE, Pierce RA, Holzman MD, et al. Cancer Survivorship: Defining the Incidence of Incisional Hernia After Resection for Intra-Abdominal Malignancy. Ann Surg Oncol. 2016;23(Suppl 5):764-71.  https://doi.org/10.1245/s10434-016-5546-z .
doi: 10.1245/s10434-016-5546-z pubmed: 27743227
Memba R, Morato O, Estalella L, Pavel MC, Llacer-Millan E, Achalandabaso M et al. Prevention of Incisional Hernia after Open Hepato-Pancreato-Biliary Surgery: A Systematic Review. Dig Surg. 2022;39(1):6-16. https://doi.org/10.1159/000521169 .
doi: 10.1159/000521169 pubmed: 34875657
Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR et al. Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg. 2004;239(6):818–25; discussion 25–7. https://doi.org/10.1097/01.sla.0000128305.90650.71 .
Nishioka Y, Kawaguchi Y, Kothari AN, Odisio BC, Vauthey JN. Prognostic and Therapeutic Implications of Tumor Biology, Including Gene Alterations, in Colorectal Liver Metastases. J Gastrointest Surg. 2021;25(6):1591-600.  https://doi.org/10.1007/s11605-021-04962-x .
doi: 10.1007/s11605-021-04962-x pubmed: 33742360
Kawaguchi Y, Kopetz S, Panettieri E, Hwang H, Wang X, Cao HST et al. Improved Survival over Time After Resection of Colorectal Liver Metastases and Clinical Impact of Multigene Alteration Testing in Patients with Metastatic Colorectal Cancer. J Gastrointest Surg. 2022;26(3):583-93. https://doi.org/10.1007/s11605-021-05110-1 .
doi: 10.1007/s11605-021-05110-1 pubmed: 34506029
Kawaguchi Y, Lillemoe HA, Panettieri E, Chun YS, Tzeng CD, Aloia TA et al. Conditional Recurrence-Free Survival after Resection of Colorectal Liver Metastases: Persistent Deleterious Association with RAS and TP53 Co-Mutation. J Am Coll Surg. 2019;229(3):286–94 e1. https://doi.org/10.1016/j.jamcollsurg.2019.04.027 .
Vauthey JN, Zorzi D, Pawlik TM. Making unresectable hepatic colorectal metastases resectable--does it work? Semin Oncol. 2005;32(6 Suppl 9):S118-22.  https://doi.org/10.1053/j.seminoncol.2005.04.030 .
doi: 10.1053/j.seminoncol.2005.04.030 pubmed: 16399448
Brouquet A, Abdalla EK, Kopetz S, Garrett CR, Overman MJ, Eng C et al. High survival rate after two-stage resection of advanced colorectal liver metastases: response-based selection and complete resection define outcome. J Clin Oncol. 2011;29(8):1083-90.  https://doi.org/10.1200/JCO.2010.32.6132 .
doi: 10.1200/JCO.2010.32.6132 pubmed: 21263087 pmcid: 3068054
Aloia TA, Zorzi D, Abdalla EK, Vauthey JN. Two-surgeon technique for hepatic parenchymal transection of the noncirrhotic liver using saline-linked cautery and ultrasonic dissection. Ann Surg. 2005;242(2):172-7.  https://doi.org/10.1097/01.sla.0000171300.62318.f4 .
doi: 10.1097/01.sla.0000171300.62318.f4 pubmed: 16041206 pmcid: 1357721
Fink C, Baumann P, Wente MN, Knebel P, Bruckner T, Ulrich A et al. Incisional hernia rate 3 years after midline laparotomy. Br J Surg. 2014;101(2):51-4.  https://doi.org/10.1002/bjs.9364 .
doi: 10.1002/bjs.9364 pubmed: 24281948
Itatsu K, Yokoyama Y, Sugawara G, Kubota H, Tojima Y, Kurumiya Y et al. Incidence of and risk factors for incisional hernia after abdominal surgery. Br J Surg. 2014;101(11):1439-47. https://doi.org/10.1002/bjs.9600 .
doi: 10.1002/bjs.9600 pubmed: 25123379
Veljkovic R, Protic M, Gluhovic A, Potic Z, Milosevic Z, Stojadinovic A. Prospective clinical trial of factors predicting the early development of incisional hernia after midline laparotomy. J Am Coll Surg. 2010;210(2):210-9.  https://doi.org/10.1016/j.jamcollsurg.2009.10.013 .
doi: 10.1016/j.jamcollsurg.2009.10.013 pubmed: 20113942
Bosanquet DC, Ansell J, Abdelrahman T, Cornish J, Harries R, Stimpson A et al. Systematic Review and Meta-Regression of Factors Affecting Midline Incisional Hernia Rates: Analysis of 14,618 Patients. PLoS One. 2015;10(9):e0138745. https://doi.org/10.1371/journal.pone.0138745 .
Bardou M, Barkun AN, Martel M. Obesity and colorectal cancer. Gut. 2013;62(6):933-47. https://doi.org/10.1136/gutjnl-2013-304701 .
doi: 10.1136/gutjnl-2013-304701 pubmed: 23481261
Liu PH, Wu K, Ng K, Zauber AG, Nguyen LH, Song M et al. Association of Obesity With Risk of Early-Onset Colorectal Cancer Among Women. JAMA Oncol. 2019;5(1):37-44. https://doi.org/10.1001/jamaoncol.2018.4280 .
doi: 10.1001/jamaoncol.2018.4280 pubmed: 30326010
Perthes G, Chir Z. Zur Schnittführung bei Operationen an den Gallenwegen. Zenthralbl f Chir. 1912;39:1252-6.
Chang SB, Palavecino M, Wray CJ, Kishi Y, Pisters PW, Vauthey JN. Modified Makuuchi incision for foregut procedures. Arch Surg. 2010;145(3):281-4.  https://doi.org/10.1001/archsurg.2010.7 .
doi: 10.1001/archsurg.2010.7 pubmed: 20231630
Santos DA, Zhang L, Do KA, Bednarski BK, Robinson Ledet C, Limmer A et al. Chemotherapy and Abdominal Wall Closure Technique Increase the Probability of Postoperative Ventral Incisional Hernia in Patients With Colon Cancer. Am Surg. 2023;89(1):98-107. https://doi.org/10.1177/00031348211011149 .
doi: 10.1177/00031348211011149 pubmed: 33877925
Nilsson JH, Strandberg Holka P, Sturesson C. Incisional hernia after open resections for colorectal liver metastases - incidence and risk factors. HPB (Oxford). 2016;18(5):436-41. https://doi.org/10.1016/j.hpb.2016.02.001 .
doi: 10.1016/j.hpb.2016.02.001 pubmed: 27154807 pmcid: 4857068
Kawaguchi Y, Kopetz S, Lillemoe HA, Hwang H, Wang X, Tzeng CD et al. A New Surveillance Algorithm After Resection of Colorectal Liver Metastases Based on Changes in Recurrence Risk and RAS Mutation Status. J Natl Compr Canc Netw. 2020;18(11):1500-8. https://doi.org/10.6004/jnccn.2020.7596 .
doi: 10.6004/jnccn.2020.7596 pubmed: 33152698 pmcid: 10547101
Chun YS, Vauthey JN, Boonsirikamchai P, Maru DM, Kopetz S, Palavecino M et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA. 2009;302(21):2338-44. https://doi.org/10.1001/jama.2009.1755 .
doi: 10.1001/jama.2009.1755 pubmed: 19952320 pmcid: 4139149
Kawaguchi Y, Kopetz S, Newhook TE, De Bellis M, Chun YS, Tzeng CD et al. Mutation Status of RAS, TP53, and SMAD4 is Superior to Mutation Status of RAS Alone for Predicting Prognosis after Resection of Colorectal Liver Metastases. Clin Cancer Res. 2019;25(19):5843-51.  https://doi.org/10.1158/1078-0432.CCR-19-0863 .
doi: 10.1158/1078-0432.CCR-19-0863 pubmed: 31221662 pmcid: 6774854
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205-13. https://doi.org/10.1097/01.sla.0000133083.54934.ae .
doi: 10.1097/01.sla.0000133083.54934.ae pubmed: 15273542 pmcid: 1360123
Gray RJ. A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk. Ann Stat. 1988;16(16):1141-54.
Kayashima H, Maeda T, Harada N, Masuda T, Guntani A, Ito S et al. Risk factors for incisional hernia after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis. Surgery. 2015;158(6):1669-75.  https://doi.org/10.1016/j.surg.2015.06.001 .
doi: 10.1016/j.surg.2015.06.001 pubmed: 26116049
D'Angelica M, Maddineni S, Fong Y, Martin RC, Cohen MS, Ben-Porat L et al. Optimal abdominal incision for partial hepatectomy: increased late complications with Mercedes-type incisions compared to extended right subcostal incisions. World J Surg. 2006;30(3):410-8. https://doi.org/10.1007/s00268-005-0183-x .
doi: 10.1007/s00268-005-0183-x pubmed: 16467983
Togo S, Nagano Y, Masumoto C, Takakura H, Matsuo K, Takeda K et al. Outcome of and risk factors for incisional hernia after partial hepatectomy. J Gastrointest Surg. 2008;12(6):1115-20. https://doi.org/10.1007/s11605-008-0469-z .
doi: 10.1007/s11605-008-0469-z pubmed: 18213504
Rosen MJ, Aydogdu K, Grafmiller K, Petro CC, Faiman GH, Prabhu A. A Multidisciplinary Approach to Medical Weight Loss Prior to Complex Abdominal Wall Reconstruction: Is it Feasible? J Gastrointest Surg. 2015;19(8):1399-406.  https://doi.org/10.1007/s11605-015-2856-6 .
doi: 10.1007/s11605-015-2856-6 pubmed: 26001369
Shindoh J, Tzeng CW, Aloia TA, Curley SA, Zimmitti G, Wei SH et al. Optimal future liver remnant in patients treated with extensive preoperative chemotherapy for colorectal liver metastases. Ann Surg Oncol. 2013;20(8):2493-500.  https://doi.org/10.1245/s10434-012-2864-7 .
doi: 10.1245/s10434-012-2864-7 pubmed: 23377564
Kishi Y, Zorzi D, Contreras CM, Maru DM, Kopetz S, Ribero D et al. Extended preoperative chemotherapy does not improve pathologic response and increases postoperative liver insufficiency after hepatic resection for colorectal liver metastases. Ann Surg Oncol. 2010;17(11):2870-6. https://doi.org/10.1245/s10434-010-1166-1 .
doi: 10.1245/s10434-010-1166-1 pubmed: 20567921
Ribero D, Wang H, Donadon M, Zorzi D, Thomas MB, Eng C et al. Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer. 2007;110(12):2761-7. https://doi.org/10.1002/cncr.23099 .
doi: 10.1002/cncr.23099 pubmed: 17960603
Arslan MK, Aydin C, Topaloglu S, Calik A, Tomas K, Karabulut E. Incidence of and Risk Factors for Incisional Hernia after Liver Surgery Performed with a J-Shaped Right Subcostal Incision. Am Surg. 2017;83(2):e49-53.
doi: 10.1177/000313481708300204 pubmed: 28228191
Payne R, Aldwinckle J, Ward S. Meta-analysis of randomised trials comparing the use of prophylactic mesh to standard midline closure in the reduction of incisional herniae. Hernia. 2017;21(6):843-53. https://doi.org/10.1007/s10029-017-1653-4 .
doi: 10.1007/s10029-017-1653-4 pubmed: 28864937
Seiler CM, Bruckner T, Diener MK, Papyan A, Golcher H, Seidlmayer C et al. Interrupted or continuous slowly absorbable sutures for closure of primary elective midline abdominal incisions: a multicenter randomized trial (INSECT: ISRCTN24023541). Ann Surg. 2009;249(4):576-82.  https://doi.org/10.1097/SLA.0b013e31819ec6c8 .
doi: 10.1097/SLA.0b013e31819ec6c8 pubmed: 19300233
Deerenberg EB, Harlaar JJ, Steyerberg EW, Lont HE, van Doorn HC, Heisterkamp J et al. Small bites versus large bites for closure of abdominal midline incisions (STITCH): a double-blind, multicentre, randomised controlled trial. Lancet. 2015;386(10000):1254-60. https://doi.org/10.1016/S0140-6736(15)60459-7 .
doi: 10.1016/S0140-6736(15)60459-7 pubmed: 26188742

Auteurs

Harufumi Maki (H)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Bradford J Kim (BJ)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Yoshikuni Kawaguchi (Y)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Ramiro Fernandez-Placencia (R)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Antony Haddad (A)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Elena Panettieri (E)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Timothy E Newhook (TE)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Donald P Baumann (DP)

Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

David Santos (D)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Hop S Tran Cao (HS)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Yun Shin Chun (YS)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Ching-Wei D Tzeng (CD)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Jean-Nicolas Vauthey (JN)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA. jvauthey@mdanderson.org.

Timothy J Vreeland (TJ)

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1484, Houston, TX, 77030, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH